Summary
Summary Hypothalamic^pituitaryĤypothalamic^pituitaryâ drenal (HPA) axis sensitivity was adrenal (HPA) axis sensitivity was investigated in 32 non-medicated patients investigated in 32 non-medicated patients with borderline personality disorder with borderline personality disorder without comorbid post-traumatic without comorbid post-traumatic syndromes and in18 normal individuals syndromes and in18 normal individuals using a modified dexamethasone using a modified dexamethasone suppression test (0.25 mg).Enhanced suppression test (0.25 mg).Enhanced cortisol suppression was found in the cortisol suppression was found in the patients patients v.
v. controls ( controls (P P5 50.05) and the 0.05) and the percentage of participant's with nonpercentage of participant's with nonsuppression was smaller in the patient suppression was smaller in the patient (34%) than in the control group (89%) (34%) than in the control group (89%) ( (P P5 50.01).Baseline cortisol levels in the 0.01).Baseline cortisollevels in the patients were also lower than in the patients were also lower than in the controls ( controls (P P5 50.05).The 0.25 mg 0.05).The 0.25 mg dexamethasone suppression test reveals dexamethasone suppression test reveals increased feedbackinhibition ofthe HPAin increased feedbackinhibition ofthe HPAin borderline personality disorder. borderline personality disorder.
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Hypothalamic-pituitary-adrenal (HPA) axis Hypothalamic-pituitary-adrenal (HPA) axis response in borderline personality disorder response in borderline personality disorder is controversial. Several studies published is controversial. Several studies published two decades ago reported high rates of two decades ago reported high rates of non-suppression with the 1 mg dexamethanon-suppression with the 1 mg dexamethasone test in patients with borderline personsone test in patients with borderline personality features, suggesting an association of ality features, suggesting an association of the condition with affective disorders the condition with affective disorders (Sternbach (Sternbach et al et al, 1983) . However, recent , 1983) . However, recent studies suggest some similarities with HPA studies suggest some similarities with HPA axis disturbances found in post-traumatic axis disturbances found in post-traumatic stress disorder (PTSD). Studies of people stress disorder (PTSD). Studies of people with PTSD have reported lower cortisol with PTSD have reported lower cortisol levels than in a normal comparison group, levels than in a normal comparison group, increased lymphocyte glucocorticoid recepincreased lymphocyte glucocorticoid receptor density and enhanced cortisol supprestor density and enhanced cortisol suppression with a 0.5 mg dexamethasone test sion with a 0.5 mg dexamethasone test (Rinne (Rinne et al et al, 2002; Yehuda , 2002; Yehuda et al et al, 2004) . , 2004). On the other hand, several studies with the On the other hand, several studies with the 0.5 mg dexamethasone test have reported 0.5 mg dexamethasone test have reported enhanced cortisol suppression in patients enhanced cortisol suppression in patients with borderline personality disorder and cowith borderline personality disorder and comorbid post-traumatic symptoms (Grossman morbid post-traumatic symptoms (Grossman et al et al, 2003 , Lange , 2003 , Lange et al et al, 2005 , but not in , 2005), but not in patients with this personality disorder but patients with this personality disorder but without PTSD. However, cortisol suppreswithout PTSD. However, cortisol suppression was very high in the normal control sion was very high in the normal control group in these studies, ranging from 70% group in these studies, ranging from 70% to 85%, which might have reduced the disto 85%, which might have reduced the discriminatory power of the 0.5 mg test. A precriminatory power of the 0.5 mg test. A preliminary study with a lower dose (0.25 mg) liminary study with a lower dose (0.25 mg) of dexamethasone (Carrasco of dexamethasone (Carrasco et al et al, 2003 (Carrasco et al et al, ) re-, 2003 reported enhanced cortisol suppression in ported enhanced cortisol suppression in borderline personality disorder with no borderline personality disorder with no comorbid PTSD compared with other percomorbid PTSD compared with other personality disorders and demonstrated high sonality disorders and demonstrated high specificity for detection of cortisol suppresspecificity for detection of cortisol suppression. However, the conclusions were limited sion. However, the conclusions were limited by the absence of a comparison group of by the absence of a comparison group of normal individuals. normal individuals.
METHOD METHOD
Patients were selected at the emergency room Patients were selected at the emergency room for repetitive self-aggressive behaviour (at for repetitive self-aggressive behaviour (at least two episodes in the preceding 6 months) least two episodes in the preceding 6 months) and evaluated by a senior psychiatrist with and evaluated by a senior psychiatrist with the Structured Clinical Interview for DSMthe Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I; First IV Axis I Disorders (SCID-I; First et al et al, , 1995) . Fifty-one patients with a diagnosis of Fifty-one patients with a diagnosis of borderline personality disorder were seborderline personality disorder were selected. Those with comorbid PTSD ( lected. Those with comorbid PTSD (n n¼4) 4) were excluded, as were those with current were excluded, as were those with current major depression ( major depression (n n¼9) or substance de-9) or substance dependence ( pendence (n n¼4) and a lifetime history of 4) and a lifetime history of bipolar disorder ( bipolar disorder (n n¼1) or schizophreniform 1) or schizophreniform disorder ( disorder (n n¼1). Finally, 32 patients with no 1). Finally, 32 patients with no major metabolic or hormonal disease enmajor metabolic or hormonal disease entered the study and were admitted to the tered the study and were admitted to the hospitalisation unit for a wash-out period hospitalisation unit for a wash-out period to eliminate medication and other drugs. to eliminate medication and other drugs. The control group included 18 healthy The control group included 18 healthy individuals recruited from a healthcare preindividuals recruited from a healthcare prevention programme and matched with the vention programme and matched with the patients for age and gender. patients for age and gender.
Biological tests followed a wash-out Biological tests followed a wash-out period of at least 1 week for anxiolytic period of at least 1 week for anxiolytic medication and 3 weeks for other medicamedication and 3 weeks for other medications and illicit drugs (5 weeks for fluoxtions and illicit drugs (5 weeks for fluoxetine). Participants were admitted to the etine). Participants were admitted to the psychoendocrinology research unit at psychoendocrinology research unit at 07.30 h on day 1. An intravenous catheter 07.30 h on day 1. An intravenous catheter was inserted at 08.00 h, allowing subsewas inserted at 08.00 h, allowing subsequent blood sampling exempt from the quent blood sampling exempt from the stress-inducing effects of needle-sticks. stress-inducing effects of needle-sticks. After 30 min, a blood sample was taken After 30 min, a blood sample was taken for measurement of plasma cortisol. At for measurement of plasma cortisol. At 23.00 h on day 1 the participants were 23.00 h on day 1 the participants were administered an oral capsule containing administered an oral capsule containing 0.25 mg dexamethasone, and on day 2 at 0.25 mg dexamethasone, and on day 2 at 08.00 h blood samples were taken again 08.00 h blood samples were taken again for cortisol measurement. Participants were for cortisol measurement. Participants were tested under strictly controlled conditions, tested under strictly controlled conditions, including minimal activity, 8 h fasting and including minimal activity, 8 h fasting and sleep from 23.00 h the previous night. sleep from 23.00 h the previous night.
Between-group comparisons employed Between-group comparisons employed analysis of covariance (ANCOVA) for differanalysis of covariance (ANCOVA) for differences in percentage cortisol suppression and ences in percentage cortisol suppression and chi-squared tests for differences in the rate chi-squared tests for differences in the rate of non-suppressor participants. Within the of non-suppressor participants. Within the patient group relationships between varipatient group relationships between variables were explored using Pearson's correlaables were explored using Pearson's correlation coefficients. All statistical analyses were tion coefficients. All statistical analyses were two-tailed with a 0.05 level of significance. two-tailed with a 0.05 level of significance. 
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S H O R T R E P O R T S H O R T R E P O R T H
Hypothalamic^pituitary^adrenal axis response ypothalamic^pituitary^adrenal axis response in borderline personality disorder in borderline personality disorder without post-traumatic features without post-traumatic features reporting enhanced cortisol suppression in borderline personality dissol suppression in borderline personality disorder to be associated specifically with PTSD order to be associated specifically with PTSD symptoms. The relationship of enhanced corsymptoms. The relationship of enhanced cortisol suppression and borderline personality tisol suppression and borderline personality disorder in our study is further supported disorder in our study is further supported by significant correlation with severity of disby significant correlation with severity of disorder (ZAN-BPD) and the lack of significant order (ZAN-BPD) and the lack of significant correlation with childhood trauma scores. correlation with childhood trauma scores.
Interestingly, the rate of comorbid Interestingly, the rate of comorbid PTSD in our patient sample (10%) was PTSD in our patient sample (10%) was lower than that reported in previous studies lower than that reported in previous studies (Grossman (Grossman et al et al, 2003; Lange , 2003; Lange et al et al, 2005) , , 2005), which found rates of PTSD comorbidity which found rates of PTSD comorbidity of 25-50%. This suggests that the patients of 25-50%. This suggests that the patients in our sample might have been clinically in our sample might have been clinically different from those in other studies, who different from those in other studies, who were recruited by advertisements or from were recruited by advertisements or from veterans' hospitals or facilities for abused veterans' hospitals or facilities for abused women. This might have increased homowomen. This might have increased homogeneity, thereby favouring detection of geneity, thereby favouring detection of biological abnormalities in borderline perbiological abnormalities in borderline personality disorder, which is composed of sonality disorder, which is composed of different clinical and biological domains. different clinical and biological domains.
Also, methodological differences might Also, methodological differences might explain the discrepancy of our results with explain the discrepancy of our results with other studies reporting high salivary baseline other studies reporting high salivary baseline cortisol levels and increased rates of noncortisol levels and increased rates of nonsuppression in borderline personality disorder suppression in borderline personality disorder (Lieb (Lieb et al et al, 2004) . In addition, methodological , 2004). In addition, methodological differences in cortisol measurement might differences in cortisol measurement might also lead to different results. We used a also lead to different results. We used a laboratory method with strictly controlled laboratory method with strictly controlled conditions of environmental stress, including conditions of environmental stress, including 30-60 min of relaxed delay before sample 30-60 min of relaxed delay before sample extraction. Ambulatory conditions for extraction. Ambulatory conditions for cortisol salivary sampling in the previously cortisol salivary sampling in the previously mentioned study might not be free of exmentioned study might not be free of external stress influences, which could account ternal stress influences, which could account for increased cortisol levels. for increased cortisol levels.
The very low dose (0.25 mg) of dexaThe very low dose (0.25 mg) of dexamethasone might be responsible for the methasone might be responsible for the strong group effect which was not found strong group effect which was not found in previous studies using 0.5 mg doses. As in previous studies using 0.5 mg doses. As predicted, 0.25 mg dexamethasone propredicted, 0.25 mg dexamethasone produced milder cortisol suppression in the duced milder cortisol suppression in the control group than the 0.5 mg dose as control group than the 0.5 mg dose as reported in previous studies (31% reported in previous studies (31% v.
v. 60-60-80%) (Rinne 80% , 2005) . Furthermore, 65% of the patients in our study were 65% of the patients in our study were categorised as complete suppressors (corticategorised as complete suppressors (cortisol level sol level 5 55 5 m mg/dl g/dl) compared with only ) compared with only 12% of controls, suggesting that the 0.25 12% of controls, suggesting that the 0.25 mg dexamethasone test could be useful for mg dexamethasone test could be useful for discriminating abnormal HPA axis funcdiscriminating abnormal HPA axis functioning in personality disorders. tioning in personality disorders.
In conclusion, our results show low In conclusion, our results show low plasma cortisol levels and enhanced cortisol plasma cortisol levels and enhanced cortisol suppression in a 0.25 mg dexamethasone suppression in a 0.25 mg dexamethasone suppression test in individuals with bordersuppression test in individuals with borderline personality disorder with no PTSD line personality disorder with no PTSD compared with healthy controls. Increased compared with healthy controls. Increased HPA feedback inhibition probably reflects HPA feedback inhibition probably reflects increased lymphocyte glucocorticoid receptor increased lymphocyte glucocorticoid receptor density, which might be secondary to predensity, which might be secondary to previous intense and persistent stress in both disvious intense and persistent stress in both disorders (Yehuda orders (Yehuda et al et al, 2004) . However, these , 2004) . However, these results apply to a specific subgroup of paresults apply to a specific subgroup of patients selected by the presence of repetitive tients selected by the presence of repetitive self-aggressive behaviours in the previous 6 self-aggressive behaviours in the previous 6 months, and should not be generalised to all months, and should not be generalised to all people with borderline personality disorder. people with borderline personality disorder. 
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